Table of Content

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Hyperlipidemia Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Drug Type
6.1 Statins
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Bile Acid Sequestrants
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Cholesterol Absorption Inhibitors
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 PCSK9 Inhibitors
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast

7 Market Breakup by End User
7.1 Hospitals
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Clinics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast

9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Amgen Inc.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 AstraZeneca Plc
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Daiichi Sankyo Company Limited
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Eli Lilly and Company
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 Esperion Therapeutics Inc.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.6 GlaxoSmithKline Pharmaceuticals Limited (GlaxoSmithKline Plc)
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Immuron Limited
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.8 Ionis Pharmaceuticals Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Merck & Co. Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Pfizer Inc.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Sanofi S.A.
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.11.4 SWOT Analysis



List of Figures

Figure 1: Global: Hyperlipidemia Drugs Market: Major Drivers and Challenges
Figure 2: Global: Hyperlipidemia Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Hyperlipidemia Drugs Market: Breakup by Drug Type (in %), 2022
Figure 4: Global: Hyperlipidemia Drugs Market: Breakup by End User (in %), 2022
Figure 5: Global: Hyperlipidemia Drugs Market: Breakup by Region (in %), 2022
Figure 6: Global: Hyperlipidemia Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 7: Global: Hyperlipidemia Drugs (Statins) Market: Sales Value (in Million US$), 2017 & 2022
Figure 8: Global: Hyperlipidemia Drugs (Statins) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 9: Global: Hyperlipidemia Drugs (Bile Acid Sequestrants) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Hyperlipidemia Drugs (Bile Acid Sequestrants) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Hyperlipidemia Drugs (Cholesterol Absorption Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Hyperlipidemia Drugs (Cholesterol Absorption Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Hyperlipidemia Drugs (PCSK9 Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Hyperlipidemia Drugs (PCSK9 Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Hyperlipidemia Drugs (Other Drug Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Hyperlipidemia Drugs (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Hyperlipidemia Drugs (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Hyperlipidemia Drugs (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Hyperlipidemia Drugs (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Hyperlipidemia Drugs (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Hyperlipidemia Drugs (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Hyperlipidemia Drugs (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: North America: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: North America: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: United States: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: United States: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Canada: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Canada: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Asia Pacific: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Asia Pacific: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: China: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: China: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Japan: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Japan: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: India: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: India: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: South Korea: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: South Korea: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Australia: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Australia: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Indonesia: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Indonesia: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Others: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Others: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Europe: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Europe: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Germany: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Germany: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: France: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: France: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: United Kingdom: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: United Kingdom: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Italy: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Italy: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Spain: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Spain: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Russia: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Russia: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Others: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Others: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Latin America: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Latin America: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Brazil: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Brazil: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Mexico: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Mexico: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Others: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Others: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Middle East and Africa: Hyperlipidemia Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Middle East and Africa: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Global: Hyperlipidemia Drugs Industry: SWOT Analysis
Figure 72: Global: Hyperlipidemia Drugs Industry: Value Chain Analysis
Figure 73: Global: Hyperlipidemia Drugs Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Hyperlipidemia Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Hyperlipidemia Drugs Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
Table 3: Global: Hyperlipidemia Drugs Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 4: Global: Hyperlipidemia Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 5: Global: Hyperlipidemia Drugs Market Structure
Table 6: Global: Hyperlipidemia Drugs Market: Key Players